SPAC Overview
Timeline Progress
- Registration2020-07-30 Filed S1
- IPO2020-09-04 IPO, search begins
- Definitive Agreement2021-04-13 Agreement for merger
- Completed2021-08-10 Merger Completed
About
BCTG Acquisition Corp. is a blank-check company seeking to complete a merger or other business combination with an unidentified business. It intends to focus on innovative biotechnology companies in North America and Europe.
Investment Focus
Biopharmaceuticals
Geographic Focus
North America, Europe
The terms and the filing trail behind BCTG Acquisition Corp.
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Underwriters
Extended Team Information
The team draws on Boxer Capital, a private biopharmaceutical investment firm with experience investing in therapeutics, including targeted oncology, and includes company founders with biotechnology investing backgrounds plus directors with expertise in oncology drug discovery, development, regulation and company leadership.